China Universal Asset Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Sell |
24,537
-1,092
| -4% | -$573K | 1.21% | 15 |
|
|
2025
Q1 | $16.3M | Buy |
25,629
+955
| +4% | +$606K | 1.51% | 12 |
|
|
2024
Q4 | $17.6M | Buy |
24,674
+9,908
| +67% | +$7.06M | 1.64% | 12 |
|
|
2024
Q3 | $15.5M | Buy |
14,766
+5,216
| +55% | +$5.48M | 1.71% | 11 |
|
|
2024
Q2 | $10M | Sell |
9,550
-6,506
| -41% | -$6.84M | 1.42% | 16 |
|
|
2024
Q1 | $15.5M | Buy |
16,056
+5,758
| +56% | +$5.54M | 1.96% | 9 |
|
|
2023
Q4 | $9.04M | Buy |
10,298
+7,351
| +249% | +$6.46M | 1.76% | 9 |
|
|
2023
Q3 | $2.43M | Buy |
2,947
+1,413
| +92% | +$1.16M | 0.7% | 40 |
|
|
2023
Q2 | $1.1M | Buy |
1,534
+45
| +3% | +$32.3K | 0.34% | 75 |
|
|
2023
Q1 | $1.22M | Buy |
1,489
+401
| +37% | +$329K | 0.41% | 65 |
|
|
2022
Q4 | $785K | Buy |
1,088
+85
| +8% | +$61.3K | 0.32% | 76 |
|
|
2022
Q3 | $691K | Buy |
+1,003
| New | +$691K | 0.29% | 71 |
|